Topics

TILT Secures New Credit Facility

19:50 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Strengthens financial profile and positions the Company for future growth TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQB: SVVTF), a leading business to business cannabis company, announced today that...

Other Sources for this Article

Contact Information:
Joel Milton
SVP of Business Development
Phone: 303-872-7255

Investor Contact:
Scott Van Winkle
ICR
Phone: 617-956-6736
investors@tiltholdings.com

Media Contact:
Cory Ziskind
ICR
Phone: 646-277-1232
tiltholdings@icrinc.com

NEXT ARTICLE

More From BioPortfolio on "TILT Secures New Credit Facility"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...